Allergy is a hyper-sensitivity to a specific substance which, if inhaled, ingested, touched or injected, causes characteristic symptoms.
ALL INMUNOTEK NEWS
According to a study published in Frontiers in Immunology, MV130 (Bactek) prevents recurrent infections in patients with malignant B-cell diseases. Respiratory ... More info
The Department of Science, Universities and Innovation of the Community of Madrid, has held a meeting with INMUNOTEK to evaluate the industrial doctorate progra... More info
"Viral Outbreaks", new book by IntechOpen, includes a chapter on trained immunity-based vaccines (TIbVs) with the participation of INMUNOTEK. These are broad-sp... More info
INNOVATING AND SHARING IDEAS
From the outset, in 1992, our goal has been to offer innovative and competitive products of the highest quality, useful for professionals and safe and effective for the treatment of patients. To this end we have put together a highly professional and motivated team; we have outstanding facilities and a broad product porfolio.
Inmunotek products are approved by the Spanish Drug Agency and several international regulatory agencies and marketed in more than 50 countries all over the world.